Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Some medications, such as Ozempic and Trulicity, are covered under the Pharmaceutical Benefits Scheme (PBS) for people with type 2 diabetes who meet certain criteria
Tagrisso is also approved to treat NSCLC with EGFR mutations in the first line metastatic setting as a monotherapy and in combination with chemotherapy, and as an adjuvant treatment for early-stage disease
Consequent changes in AUC, C max, and T max values of orally administered concomitant medications may occur, which could impact drug efficacy or safety
US$ 29.76
US$ 28.66
US$ 22.52
US$ 25.70
US$ 19.99
US$ 25.77
